Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
The Definition and Prevalence of Obesity and Metabolic Syndrome
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_1 · Cited by 1,180
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Morbidity and mortality associated with obesity
Abdelaal, M., le Roux, C. W., & Docherty, N. G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.03.107 · Cited by 1,052
“Obesity is associated with increased risk of breast cancer recurrence and mortality in both pre and postmenopausal women (83,84).”
BackgroundAune, D., Sen, A., Prasad, M., Norat, T., Janszky, I., Tonstad, S., Romundstad, P., & Vatten, L. J. (2016) · BMJ · doi:10.1136/bmj.i2156 · Cited by 953
Self-citationPicon‐Ruiz, M., Morata‐Tarifa, C., Valle‐Goffin, J. J., Friedman, E. R., & Slingerland, J. M. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21405 · Cited by 893
“53) women.(73) In the Multiethnic Cohort Study, obesity was associated with higher all-cause and breast cancer-specific mortality irre-”
BackgroundAmerican Cancer Society nutrition and physical activity guideline for cancer survivors
Rock, C. L., Thomson, C. A., Sullivan, K. R., Howe, C. L., Kushi, L. H., Caan, B. J., Neuhouser, M. L., Bandera, E. V., Wang, Y., Robien, K., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21719 · Cited by 741
Self-citationRunowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline
Ligibel, J. A., Bohlke, K., May, A. M., Clinton, S. K., Demark-Wahnefried, W., Gilchrist, S. C., Irwin, M. L., Late, M., Mansfield, S., Marshall, T. F., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00687 · Cited by 700
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
Pati, S., Irfan, W., Jameel, A., Ahmed, S., & Shahid, R. K. (2023) · Cancers · doi:10.3390/cancers15020485 · Cited by 677
“A meta-analysis of 82 studies of breast cancer survivors showed that obesity increases the risk of breast cancer-specific and all-cause mortality by 35% and 41%, respectively [94].”
BackgroundMetabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Vander Heiden, M. G., & Locasale, J. W. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 648
The Obesity Paradox in Cancer: a Review
Lennon, H., Sperrin, M., Badrick, E., & Renehan, A. G. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0539-4 · Cited by 610
Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)
Smolarz, B., Nowak, A. Z., & Romanowicz, H. (2022) · Cancers · doi:10.3390/cancers14102569 · Cited by 587
“Furthermore, according to the results of numerous studies, overweight and obesity are associated with a worse prognosis of breast cancer patients before and after menopause [55,59,60].”
ResultCaan, B. J., Cespedes Feliciano, E. M., Prado, C. M., Alexeeff, S., Kroenke, C. H., Bradshaw, P., Quesenberry, C. P., Weltzien, E. K., Castillo, A. L., Olobatuyi, T. A., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0137 · Cited by 565
Global patterns in excess body weight and the associated cancer burden
Sung, H., Siegel, R. L., Torre, L. A., Pearson‐Stuttard, J., Islami, F., Fedewa, S. A., Goding Sauer, A., Shuval, K., Gapstur, S. M., Jacobs, E. J., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21499 · Cited by 548
Petrelli, F., Cortellini, A., Indini, A., Tomasello, G., Ghidini, M., Nigro, O., Salati, M., Dottorini, L., Iaculli, A., Varricchio, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.3520 · Cited by 530
American Society of Clinical Oncology Position Statement on Obesity and Cancer
Ligibel, J. A., Alfano, C. M., Courneya, K. S., Demark-Wahnefried, W., Burger, R. A., Chlebowski, R. T., Fabian, C. J., Gucalp, A., Hershman, D. L., Hudson, M. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.4680 · Cited by 526
“● A recent meta-analysis of 82 studies including more than 200,000 patients with breast cancer demonstrated a 75% increase in mortality in premenopausal women and a 34% increase in mortality in postmenopausal women who were obese at the time of breast cancer diagnosis, as compared with patients who were of normal weig…”
ResultPathophysiology of obesity and its associated diseases
Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.012 · Cited by 499
Cancer-associated adipocytes: key players in breast cancer progression
Wu, Q., Li, B., Li, Z., Li, J., Sun, S., & Sun, S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0778-6 · Cited by 462
Obesity and cancer: inflammation bridges the two
Kolb, R., Sutterwala, F. S., & Zhang, W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.005 · Cited by 405
Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities
Jiralerspong, S., & Goodwin, P. J. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.4480 · Cited by 405
Nutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence
De Cicco, P., Catani, M. V., Gasperi, V., Sibilano, M., Quaglietta, M., & Savini, I. (2019) · Nutrients · doi:10.3390/nu11071514 · Cited by 403
“In particular, an increased risk of 17%, 11% and 8% for overall mortality and 18%, 14% and 29% for BC-specific mortality has been observed for each 5 kg/m2 BMI increment (i) before BC diagnosis, (ii) less than 12 months after diagnosis and (iii) 12 or more months after diagnosis, respectively [22].”
BackgroundBodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Primary and secondary prevention of breast cancer
Kolak, A., Kamińska, M., Sygit, K., Budny, A., Surdyka, D., Kukiełka-Budny, B., & Burdan, F. (2017) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/75943 · Cited by 350
“The significance of obesity as a risk factor is increasing with age, especially after menopause [6, 25, 26], since tumours are characterized by worse response to treatment and great risk of relapse in this period [6, 27], whereas women before and after menopause are characterized by worse survival [28].”
BackgroundPlaydon, M. C., Bracken, M. B., Sanft, T. B., Ligibel, J. A., Harrigan, M., & Irwin, M. L. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv275 · Cited by 309
“Evidence including a systematic review and meta-analysis of 82 studies suggests that obesity is also associated with breast cancer incidence and mortality in premenopausal women (18,19), even after adjustment for methodological biases and stratification by histological subtype (5,20,21).”
BackgroundHyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 305
Obesity and cancer: An update of the global impact
Arnold, M., Leitzmann, M., Freisling, H., Bray, F., Romieu, I., Renehan, A., & Soerjomataram, I. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.01.003 · Cited by 300
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Adipocyte biology in breast cancer: From silent bystander to active facilitator
Choi, J., Cha, Y. J., & Koo, J. S. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.11.002 · Cited by 255
Recent Research on Flavonoids and their Biomedical Applications
Wen, K., Fang, X., Yang, J., Yao, Y., Nandakumar, K. S., Salem, M. L., & Cheng, K. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200713184138 · Cited by 255
Practical clinical interventions for diet, physical activity, and weight control in cancer survivors
Demark‐Wahnefried, W., Rogers, L. Q., Alfano, C. M., Thomson, C. A., Courneya, K. S., Meyerhardt, J. A., Stout, N. L., Kvale, E., Ganzer, H., & Ligibel, J. A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21265 · Cited by 251
“A recent meta-analysis of 82 studies that included 213,075 women with breast cancer demonstrated that, for each 5-kg/m(2) increment in body mass index (BMI), there was a 14% to 29% increased risk of disease-specific mortality and an 8% to 17% increased risk of total mortality.(12) Results of a similar magnitude were o…”
BackgroundResultCeci, C., Atzori, M. G., Lacal, P. M., & Graziani, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041388 · Cited by 246
Obesity, DNA Damage, and Development of Obesity-Related Diseases
Włodarczyk, M., & Nowicka, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051146 · Cited by 242
“In this case, obesity was associated with poorer breast cancer survival regardless of BMI ascertainment period [126].”
BackgroundBhardwaj, P., Au, C. C., Benito-Martin, A., Ladumor, H., Oshchepkova, S., Moges, R., & Brown, K. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.002 · Cited by 233
Chan, D. S. M., Abar, L., Cariolou, M., Nanu, N., Greenwood, D. C., Bandera, E. V., McTiernan, A., & Norat, T. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01223-w · Cited by 226
Self-citationThe Importance of Body Composition in Explaining the Overweight Paradox in Cancer—Counterpoint
Caan, B. J., Cespedes Feliciano, E. M., & Kroenke, C. H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3287 · Cited by 224
Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms
Andò, S., Gelsomino, L., Panza, S., Giordano, C., Bonofiglio, D., Barone, I., & Catalano, S. (2019) · Cancers · doi:10.3390/cancers11010062 · Cited by 212
“There was no evidence on the differential interaction of obesity and mortality in relation to hormone receptor status of cancer [68,70].”
BackgroundCancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Klil-Drori, A. J., Azoulay, L., & Pollak, M. N. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.120 · Cited by 210
Impact of the Obesity Epidemic on Cancer
Goodwin, P. J., & Stambolic, V. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051613-012328 · Cited by 205
Extracellular superoxide dismutase and its role in cancer
Griess, B., Tom, E., Domann, F., & Teoh-Fitzgerald, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.013 · Cited by 195
Contribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
“Additionally, in patients with confirmed breast cancers, obesity is associated with increased risk of breast cancer invasion (143, 272), development of distant metastases (111, 247, 294), tumor recurrence (42, 346), and mortality (2, 24, 55, 64, 84, 229, 420, 436) irrespective of molecular subtype.”
Obesity and Cancer: Evidence, Impact, and Future Directions
Colditz, G. A., & Peterson, L. L. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.277376 · Cited by 187
Harrigan, M., Cartmel, B., Loftfield, E., Sanft, T., Chagpar, A. B., Zhou, Y., Playdon, M., Li, F., & Irwin, M. L. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6375 · Cited by 186
Adult obesity complications: challenges and clinical impact
Ansari, S., Haboubi, H., & Haboubi, N. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934955 · Cited by 184
Wallington, M., Saxon, E. B., Bomb, M., Smittenaar, R., Wickenden, M., McPhail, S., Rashbass, J., Chao, D., Dewar, J., Talbot, D., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30383-7 · Cited by 181
Picon-Ruiz, M., Pan, C., Drews-Elger, K., Jang, K., Besser, A. H., Zhao, D., Morata-Tarifa, C., Kim, M., Ince, T. A., Azzam, D. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0927 · Cited by 180
Obesity and cancer: mechanistic insights from transdisciplinary studies
Allott, E. H., & Hursting, S. D. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0400 · Cited by 179
Obesity-associated Breast Cancer: Analysis of risk factors
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_25 · Cited by 178
Impact of body composition on outcome in patients with early breast cancer
Deluche, É., Léobon, S., Desport, J., Venat‐Bouvet, L., Usseglio, J., & Tubiana-Mathieu, N. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3902-6 · Cited by 177
Carayol, M., Ninot, G., Sénesse, P., Bleuse, J., Gourgou, S., Sancho-Garnier, H., Sari, C., Romieu, I., Romieu, G., & Jacot, W. (2019) · BMC Cancer · doi:10.1186/s12885-019-5896-6 · Cited by 176
Weight management and physical activity throughout the cancer care continuum
Demark‐Wahnefried, W., Schmitz, K. H., Alfano, C. M., Bail, J. R., Goodwin, P. J., Thomson, C. A., Bradley, D. W., Courneya, K. S., Befort, C. A., Denlinger, C. S., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21441 · Cited by 172
“A meta-analysis of 82 studies involving 213,075 women with breast cancer found a 41% relative increase in all-cause mortality for women with obesity versus those of normal weight (relative increases were 75% in premenopausal women and 34% in postmenopausal women).(9) That study also reported increased all-cause mortal…”
BackgroundThe Impact of Obesity on Breast Cancer
Argolo, D. F. S. D. T. E., Hudis, C. A., & Iyengar, N. M. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0688-8 · Cited by 170
Obesity Paradox: Fact or Fiction?
Simati, S., Kokkinos, A., Dalamaga, M., & Argyrakopoulou, G. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00497-1 · Cited by 169
Obesity and colorectal cancer: molecular features of adipose tissue
Martinez-Useros, J., & Garcia-Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 167
“Obesity is one of the risk factors such as gender, race, dietary habits or smoking history that has been linked to the most relevant cancers like breast [3], gynaecological [4], liver [5] and colorectal cancer (CRC) [6].”
BackgroundCancer Epidemiology: A Survey of Modifiable Risk Factors for Prevention and Survivorship
Arem, H. E., & Loftfield, E. (2017) · American Journal of Lifestyle Medicine · doi:10.1177/1559827617700600 · Cited by 168
“Studies of cancer survivors suggest poorer outcomes among obese patients, with the most evidence for breast cancer.(27,36) Still, mechanisms underlying the observed associations between obesity and survival, for instance among women with breast cancer, are poorly understood, and more research is needed to understand h…”
BackgroundThe Obesity Paradox in Cancer: Epidemiologic Insights and Perspectives
Lee, D. H., & Giovannucci, E. L. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00280-6 · Cited by 167
Updating the role of obesity and cholesterol in breast cancer
Garcia-Estevez, L., & Moreno-Bueno, G. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1124-1 · Cited by 165
European Code against Cancer 4th Edition: Obesity, body fatness and cancer
Anderson, A. S., Key, T. J., Norat, T., Scoccianti, C., Cecchini, M., Berrino, F., Boutron‐Ruault, M., Espina, C., Leitzmann, M. F., Powers, H. J., et al. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.01.017 · Cited by 165
Self-citationGolubnitschaja, O., Debald, M., Yeghiazaryan, K., Kuhn, W. C., Pešta, M., Costigliola, V., & Grech, G. (2016) · Tumor Biology · doi:10.1007/s13277-016-5168-x · Cited by 162
“ly higher risk for BC diagnosis and mortality compared to the standard range BMI = 20–25 [75].”
BackgroundObesity, Dietary Factors, Nutrition, and Breast Cancer Risk
Seiler, A., Chen, M. A., Brown, R. L., & Fagundes, C. P. (2018) · Current Breast Cancer Reports · doi:10.1007/s12609-018-0264-0 · Cited by 162
“In contrast, lifestyle choices such as unbalanced diet, lack of physical activity, high body mass index (BMI), and high alcohol and/or tobacco consumption are deemed modifiable [4].”
InfluentialAdipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin
Sheng, X., Parmentier, J., Tucci, J., Pei, H., Cortez-Toledo, O., Dieli-Conwright, C. M., Oberley, M. J., Neely, M. N., Orgel, E., Louie, S. G., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0338 · Cited by 156
“While obesity has been linked with poorer outcome from several cancers, including that of the breast (2), colon (3), ovary (4), and prostate (5), no mechanisms have been proven to explain these effects.”
BackgroundPlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity
Incio, J., Tam, J., Rahbari, N. N., Suboj, P., McManus, D. T., Chin, S. M., Vardam, T. D., Batista, A., Babykutty, S., Jung, K., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1839 · Cited by 134
Lalami, Y., & Klastersky, J. A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.11.005 · Cited by 150
Chlebowski, R. T., Aragaki, A. K., Anderson, G. L., Thomson, C. A., Manson, J. E., Simon, M. S., Howard, B. V., Rohan, T. E., Snetselar, L., Lane, D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.72.0326 · Cited by 137
Bandera, E. V., Maskarinec, G., Romieu, I., & John, E. M. (2015) · Advances in Nutrition · doi:10.3945/an.115.009647 · Cited by 150
Self-citationThe Plausibility of Obesity Paradox in Cancer—Point
Park, Y., Peterson, L. L., & Colditz, G. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3043 · Cited by 142
“A metaanalysis of breast cancer survivor studies summarized that obesity assessed less than 12 months after cancer diagnosis and 12 months or more after cancer diagnosis was related to 23% and 21% increased risk of death, respectively, compared to normal weight (10).”
BackgroundLehuédé, C., Li, X., Dauvillier, S., Vaysse, C., Franchet, C., Clement, E., Estève, D., Longué, M., Chaltiel, L., Gonidec, S. L., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-018-1088-6 · Cited by 142
Henley, S. J., Thomas, C. C., Lewis, D. R., Ward, E., Islami, F., Wu, M., Weir, H. K., Scott, S., Sherman, R., Ma, J., et al. (2020) · Cancer · doi:10.1002/cncr.32801 · Cited by 141
Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis
Lohmann, A. E., Soldera, S. V., Pimentel, I., Ribnikar, D., Ennis, M., Amir, E., & Goodwin, P. J. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab023 · Cited by 141
“AND prognosis/or disease-free survival/or medical futility/or treatment outcome/or treatment failure/ or disease progression/or remission, spontaneous/or morbidity/or incidence/or prevalence/or mortality/or “cause of death”/or fatal outcome/or mortality, premature/or survival rate/ survival analysis/or disease-free su…”
BackgroundInfluentialBreast cancer survival among young women: a review of the role of modifiable lifestyle factors
Brenner, D. R., Brockton, N. T., Kotsopoulos, J., Cotterchio, M., Boucher, B. A., Courneya, K. S., Knight, J. A., Olivotto, I. A., Quan, M. L., & Friedenreich, C. M. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0726-5 · Cited by 140
Shepshelovich, D., Xu, W., Lü, L., Fares, A. F., Yang, P., Christiani, D. C., Zhang, J., Shiraishi, K., Ryan, B. M., Chen, C., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.031 · Cited by 140
Effects of short-term fasting on cancer treatment
de Groot, S., Pijl, H., van der Hoeven, J. J. M., & Kroep, J. R. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1189-9 · Cited by 128
“Metabolic risk factors for cancer Obesity is associated with an increased risk of developing several cancers, such as breast cancer, colon cancer, ovarian cancer, endometrial cancer and thyroid cancer [96, 97] and IGF-1 levels are positively associated with the risk of developing breast and prostate cancer [98, 99].”
BackgroundAdipocyte–Tumor Cell Metabolic Crosstalk in Breast Cancer
Hoy, A. J., Balaban, S., & Saunders, D. N. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.009 · Cited by 139
Blair, C. K., Wiggins, C. L., Nibbe, A. M., Storlie, C. B., Prossnitz, E. R., Royce, M., Lomo, L. C., & Hill, D. A. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0128-4 · Cited by 139
Abubakar, M., Sung, H., Devi, B. C. R., Guida, J., Tang, T. S., Pfeiffer, R. M., & Yang, X. R. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1033-8 · Cited by 138
The obesity-breast cancer link: a multidisciplinary perspective
Devericks, E. N., Carson, M. S., McCullough, L. E., Coleman, M. F., & Hursting, S. D. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10043-5 · Cited by 138
Barone, I., Giordano, C., Bonofiglio, D., Andò, S., & Catalano, S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.001 · Cited by 137
Body weight management in overweight and obese breast cancer survivors
Shaikh, H., Bradhurst, P., Li, X., Tan, S. Y., Egger, S. J., & Vardy, J. L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012110.pub2 · Cited by 137
Gérard, C., & Brown, K. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.014 · Cited by 136
“mortality risk increases in both pre- and postmenopausal obese women compared with normal weight women [23, 24].”
Nechuta, S., Chen, W. Y., Cai, H., Poole, E. M., Kwan, M. L., Flatt, S. W., Patterson, R. E., Pierce, J. P., Caan, B. J., & Shu, X. O. (2015) · International Journal of Cancer · doi:10.1002/ijc.29940 · Cited by 136
Fontanella, C., Lederer, B., Gade, S., Vanoppen, M., Blohmer, J., Costa, S. D., Denkert, C., Eidtmann, H., Gerber, B., Hanusch, C. A., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3287-5 · Cited by 134
“Moreover, it has also been assessed that the negative impact of BMI on BC longterm treatment outcome is independent of when BMI is ascertained [16].”
BackgroundBone metastasis risk factors in breast cancer
Pulido, C., Vendrell, I., Ferreira, A. R., Casimiro, S., Mansinho, A., Alho, I., & Costa, L. (2017) · ecancermedicalscience · doi:10.3332/ecancer.2017.715 · Cited by 134
Hamer, J., & Warner, E. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.160464 · Cited by 134
Antoni, M. H., Moreno, P. I., & Penedo, F. J. (2023) · Annual Review of Psychology · doi:10.1146/annurev-psych-030122-124119 · Cited by 132
Weight Management and Physical Activity for Breast Cancer Prevention and Control
Ligibel, J. A., Basen‐Engquist, K., & Bea, J. W. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_237423 · Cited by 133
Chu, D., Nguyen, T. T. P., Tien, N. L. B., Khoa, T. D., Nguyen, T.-T., Thanh, V. V., Quang, T. L., Bui, L. M., Pham, V.-H., Ngọc, V. T. N., et al. (2019) · Cells · doi:10.3390/cells8080857 · Cited by 133
“Moreover, the mortality rate caused by breast cancer is much higher in obese people compared to lean people [11].”
BackgroundObesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications
Simone, V. D., d’Avenia, M., Argentiero, A., Felici, C., Rizzo, F. M., Pergola, G. D., & Silvestris, F. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0351 · Cited by 130
Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed
Vijayvergia, N., & Denlinger, C. S. (2015) · Journal of Personalized Medicine · doi:10.3390/jpm5030243 · Cited by 128
“A meta-analysis of over 200,000 breast cancer patients demonstrated a 75% and 34% increase in mortality among obese pre- and postmenopausal women, respectively, as compared with patients who were of normal weight at diagnosis [25].”
ResultProvatopoulou, X., Georgiou, G. P., Kalogera, E., Kalles, V., Matiatou, M. A., Papapanagiotou, I., Sagkriotis, A., Zografos, G. C., & Gounaris, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1898-1 · Cited by 118
“Obese women are at an increased risk of breast cancer and typically present more aggressive disease, poorer outcomes and higher mortality rates [21–25].”
BackgroundQureshi, R., Picon-Ruiz, M., Aurrekoetxea-Rodriguez, I., Nunes de Paiva, V., D’Amico, M., Yoon, H., Radhakrishnan, R., Morata-Tarifa, C., Ince, T., Lippman, M. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.008 · Cited by 127
Ligibel, J. A., Jones, L. W., Brewster, A. M., Clinton, S. K., Korde, L. A., Oeffinger, K. C., Bender, C. M., Tan, W., Merrill, J. K., Katta, S., et al. (2019) · Journal of Oncology Practice · doi:10.1200/jop.19.00124 · Cited by 126
“Observational studies have demonstrated a relationship between obesity at the time of cancer diagnosis and an increased risk of cancer recurrence and cancer-related mortality in individuals with early-stage, potentially curable malignancies.(3,5,10,13) In addition, obesity has been linked to an increased risk of secon…”
BackgroundThe impact of health insurance on cancer care in disadvantaged communities
Abdelsattar, Z. M., Hendren, S. K., & Wong, S. L. (2016) · Cancer · doi:10.1002/cncr.30431 · Cited by 126
Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype
Dibaba, D. T., Ogunsina, K., Braithwaite, D., & Akinyemiju, T. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5056-8 · Cited by 113
“While obesity, a major component of MetS, is recognized as an established risk factor for breast cancer among post-menopausal women [21], obesity is also a risk factor for breast cancer mortality among women of all ages [22, 23].”
BackgroundNew Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis
Harborg, S., Kjærgaard, K. A., Thomsen, R. W., Borgquist, S., Cronin-Fenton, D. P., & Hjorth, C. F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad450 · Cited by 124
Bunevičienė, I., Mekary, R. A., Smith, T. R., Onnela, J.-P. “., & Bunevičius, A. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103123 · Cited by 123
“Obesity is associated with increased site-specific and overall mortality of cancer patients (Parekh et al., 2012; Calle et al., 2003; Wolin et al., 2010; Chan et al., 2014).”
Madak-Erdogan, Z., Band, S., Zhao, Y. C., Smith, B. P., Kulkoyluoglu-Cotul, E., Zuo, Q., Santaliz Casiano, A., Wrobel, K., Rossi, G., Smith, R. L., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2849 · Cited by 114
“Eighty-two different studies including analysis of more than 200,000 women with breast cancer showed that obesity increases mortality both in premenopausal and postmenopausal women (8).”
BackgroundWidschwendter, P., Friedl, T. W., Schwentner, L., DeGregorio, N., Jaeger, B., Schramm, A., Bekes, I., Deniz, M., Lato, K., Weissenbacher, T., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0639-3 · Cited by 114
“The overall negative effect of obesity on outcomes in breast cancer patients is well known and has recently been confirmed by two large meta-analyses [3, 12].”
Thomas, G. A., Cartmel, B., Harrigan, M., Fiellin, M., Capozza, S., Zhou, Y., Ercolano, E., Gross, C. P., Hershman, D., Ligibel, J., et al. (2017) · Obesity · doi:10.1002/oby.21729 · Cited by 106
“Findings from a recent meta-analysis showed that in comparison with lean participants, participants with obesity had a 35% higher risk of breast cancer-related death and a 41% higher risk of all-cause mortality (7).”
ResultObesity and breast cancer: A case of inflamed adipose tissue
Kolb, R., & Zhang, W. (2020) · Cancers · doi:10.3390/cancers12061686 · Cited by 119
“This increase in mortality was independent of menopausal and ER status [57].”
BackgroundNutritional Factors during and after Cancer: Impacts on Survival and Quality of Life
Salas, S., Cottet, V., Dossus, L., Fassier, P., Ginhac, J., Latino‐Martel, P., Romieu, I., Schneider, S. M., Srour, B., Touillaud, M. S., et al. (2022) · Nutrients · doi:10.3390/nu14142958 · Cited by 117
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.